Innovent Biologics (1801N) Q2 2021 Earnings Report
MX:1801N Q2 2021 EPS Results
- Actual EPS
- -MXN 2.27
- Consensus EPS
- -MXN 4.48
- Beat/Miss
- Beat by +MXN 2.21
- One Year Ago EPS
- -MXN 1.29
MX:1801N Q2 2021 Revenue Results
- Actual Revenue
- MXN 5.54B
- Expected Revenue
- MXN 10.86B
- Beat/Miss
- Missed by -MXN 5.32B
- YoY Revenue Growth
- +114.55%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/25/2021
- Time
- TBA
- Conference Call
- Wednesday, August 25, 2021
MX:1801N Upcoming Earnings
Innovent Biologics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:1801N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | 3.11- | -0.03 | ― | ― |
| Aug 25, 2026 | 2026 (Q2) | 1.321.96 | 1.43 | 37.25% (+0.53) | |
| Mar 26, 2026 | 2025 (Q4) | 0.34-0.03 | 0.5 | -105.56% (-0.53) | |
| Aug 27, 2025 | 2025 (Q2) | 0.501.43 | -0.67 | 312.50% (+2.10) | |
| Mar 26, 2025 | 2024 (Q4) | -0.640.50 | -1.59 | 131.69% (+2.09) | |
| Aug 28, 2024 | 2024 (Q2) | -0.70-0.67 | -0.25 | -166.67% (-0.42) | |
| Mar 20, 2024 | 2023 (Q4) | -1.96-1.59 | -2.35 | 32.38% (+0.76) | |
| Aug 23, 2023 | 2023 (Q2) | -1.88-0.25 | -1.82 | 86.15% (+1.57) | |
| Mar 31, 2023 | 2022 (Q4) | -1.85-2.35 | -3.78 | 37.78% (+1.43) | |
| Aug 25, 2022 | 2022 (Q2) | -19.04-1.82 | -2.27 | 19.75% (+0.45) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
